Rojo F, de Cangas R, Bahamonde JR, Cuello Carnero J. Rendimiento diagnóstico de la diferencia entre el diámetro sagital y el espesor de grasa subcutánea, para predecir obesidad abdominal en mujeres con exceso de peso. Toledo; 21-22 noviembre 2025.
Bibliografía
(1) Portincasa P, Frühbeck G. Phenotyping the obesities: reality or utopia? Rev Endocr Metab Disord. 2023;24(5):767-73.
(2) Das SK. Body composition measurement in severe obesity. Curr Opin Clin Nutr Metab Care. 2005;8(6):602-6.
(3) Polcrova A, Pavlovska I, Maranhao Neto GA, Kunzova S, Infante?Garcia MM, Medina?Inojosa JR, et al. Visceral fat area and cardiometabolic risk: The Kardiovize study. Obes Res Clin Pract. 2021;15(4):368–374.
(4) Ogawa H, Fujitani K, Tsujinaka T, Imanishi K, Shirakata H, Kantani A, et al. InBody 720 as a new method of evaluating visceral obesity. Hepatogastroenterology. 2011;58(105):42-4.
(5) Smith-Ryan AE, Fultz SN, Melvin MN, Wingfield HL, Woessner MN. Reproducibility and validity of A-mode ultrasound for body composition measurement and classification in overweight and obese men and women. PLoS One. 2014;9(3):e9175.
(6) Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al.; STARD Group. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
(7) Hess AS, Shardell M, Johnson JK, Thom KA, Strassle P, Netzer G, Harris AD. Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin Microbiol Infect Dis. 2012;31(9):2111–6.
(8) Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Hoboken, NJ: Wiley; 2013.
(9) Guyatt G, Rennie D, Meade MO, Cook DJ, editors. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. New York: McGraw-Hill Education; 2015.
(10) Power M, Fell G, Wright M. Principles for high-quality, high-value testing. Evid Based Med. 2013;18(1):5-10.